Search

everythinglearnresearchcommunity

for

Search:↓

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

New cytokine-targeted therapies show promise for treating alopecia areata.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

IL-6 from stem cells helps repair skin and grow hair.

Stress hormones like cortisol may trigger psoriasis flare-ups.

Spermidine may improve skin health and hair growth by enhancing cell function.

ACKR2 helps prevent skin scarring and hair loss by controlling inflammation.

Spt4 and Spt6 are essential for fat cell development.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

A 589 nm laser increases IL-2 and IFN-y gene expression in human T-cells.

CTHRC1 helps sweat glands recover by rebuilding nearby blood vessels.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

NCSTN gene mutation causes abnormal skin cell differentiation and more inflammation, contributing to Hidradenitis Suppurativa.

TAK-279 effectively reduces psoriasis symptoms and is safe.

S100A4 promotes aggressive ovarian cancer and is a potential treatment target.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

STAT5 and Sox18 are crucial for hair growth and wound healing.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

Inhibiting HSP90 increases cell adaptability and survival under stress.

Skin cells release substances important for healing and fighting infection, and understanding these could improve skin disorder treatments.

Age-related immune changes significantly affect disease development in other systems.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Mice with extra PKCδ resist chemical-induced skin cancer but not UV-induced.

Kaposi's sarcoma lesions might originate from benign tissue changes.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Plakophilin 1 helps control skin cell immune responses to prevent excessive inflammation.

IL-1β inhibits human hair follicle growth.